Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib vs Chemotherapy in Never-Smokers with Lung Adenocarcinoma
NCT00455936Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2005
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in lung adenocarcinoma, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Oct 2005; status: completed.
02
Drugs
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00455936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455936.